Cargando…
Macrophages promote anti-androgen resistance in prostate cancer bone disease
Metastatic castration-resistant prostate cancer (PC) is the final stage of PC that acquires resistance to androgen deprivation therapies (ADT). Despite progresses in understanding of disease mechanisms, the specific contribution of the metastatic microenvironment to ADT resistance remains largely un...
Autores principales: | Li, Xue-Feng, Selli, Cigdem, Zhou, Han-Lin, Cao, Jian, Wu, Shuiqing, Ma, Ruo-Yu, Lu, Ye, Zhang, Cheng-Bin, Xun, Bijie, Lam, Alyson D., Pang, Xiao-Cong, Fernando, Anu, Zhang, Zeda, Unciti-Broceta, Asier, Carragher, Neil O., Ramachandran, Prakash, Henderson, Neil C., Sun, Ling-Ling, Hu, Hai-Yan, Li, Gui-Bo, Sawyers, Charles, Qian, Bin-Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948761/ https://www.ncbi.nlm.nih.gov/pubmed/36749798 http://dx.doi.org/10.1084/jem.20221007 |
Ejemplares similares
-
Palladium-Mediated Dealkylation of N-Propargyl-Floxuridine as a Bioorthogonal Oxygen-Independent Prodrug Strategy
por: Weiss, Jason T., et al.
Publicado: (2015) -
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold
por: Baillache, Daniel J., et al.
Publicado: (2020) -
Targeted Molecular Construct for Bioorthogonal Theranostics
of PD-L1-Expressing Cancer Cells
por: Chow, Shiao Y., et al.
Publicado: (2022) -
Development and Bioorthogonal Activation of Palladium-Labile
Prodrugs of Gemcitabine
por: Weiss, Jason T., et al.
Publicado: (2014) -
Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach
por: Weiss, Jason T., et al.
Publicado: (2014)